Singapore markets close in 5 hours 21 minutes
Straits Times Index
3,308.01 +11.12 (+0.34%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,400.54 +193.41 (+1.06%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,727.30 +2,241.87 (+3.90%) CMC Crypto 200
1,288.99 +18.25 (+1.43%)
GSK plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:19PM BST
| Previous close | 1,705.00 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 8,263,272 |
| Market cap | 70.489B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 15.86 |
| EPS (TTM) | 1.09 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.60 (3.52%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
Simply Wall St.GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
BenzingaGSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
PA Media: MoneyGSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.